NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of ChromaDex Corporation (NASDAQ:CDXC) resulting from allegations that ChromaDex may have issued materially misleading business information to the investing public.

On June 20, 2016, Bleecker Street Research published a report on ChromaDex asserting, among other things, that ChromaDex shareholder Barry Honig had used a network of puppet directors and officers to secretly control ChromaDex. Bleecker Street Research also alleged that ChromaDex’s profitability for the first quarter of 2016 is “likely fake” and “appears to be engineered.” On this news, shares of ChromaDex fell $2.14 per share, or over 42%, from its previous closing price to close at $2.84 per share on June 20, 2016.

Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by ChromaDex investors. If you purchased shares of ChromaDex on or before June 17, 2016, please visit the website at http://rosenlegal.com/cases-912.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.